Rare diseases
Investigational molecules
Locations
Back to Portugal673 clinical trials in Almada, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Study on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis
PortugalStudy of Ravulizumab to Prevent Delayed Graft Function in Adult Patients After Kidney Transplant
PortugalStudy on the Effects of Ribociclib and Endocrine Therapy for Patients with HR-Positive, HER2-Negative Early Breast Cancer
PortugalTitle: Study of LP352 (bexicaserin) oral solution versus placebo for treating seizures in children and adults with Developmental and Epileptic Encephalopathies
PortugalStudy on Macitentan for Children with Pulmonary Arterial Hypertension
PortugalStudy Comparing Axatilimab to Best Available Therapy for Patients with Chronic Graft-Versus-Host Disease After Two or More Treatments
PortugalStudy on the Effects of Remibrutinib for Adults with Moderate to Severe Hidradenitis Suppurativa
PortugalStudy on the Effects of Bexicaserin for Treating Seizures in Children and Adults with Dravet Syndrome
PortugalStudy on the Effectiveness and Safety of Efgartigimod PH20 SC for Adults with Systemic Sclerosis
PortugalStudy on the Effectiveness and Safety of Efgartigimod in Adults with Ocular Myasthenia Gravis
PortugalStudy Comparing Acasunlimab and Pembrolizumab with Docetaxel for Patients with Metastatic Non-Small Cell Lung Cancer After Previous Treatments
PortugalStudy on Dupilumab for Itch Relief in Adults with Lichen Simplex Chronicus (Neurodermatitis)
PortugalThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on pulmonary arterial hypertension and chronic obstructive pulmonary disease, evaluating novel treatments including ralinepag and itepekimab for long-term management of these conditions.
Research investigating treatments for systemic lupus erythematosus, rheumatoid arthritis, and other inflammatory conditions, with studies on medications like upadacitinib and remibrutinib.
Studies examining treatments for multiple sclerosis, migraine prevention, and neurological conditions, testing medications such as ocrelizumab and atogepant.
Investigations into hypertrophic cardiomyopathy and stroke prevention, studying treatments like mavacamten and asundexian for improved cardiac outcomes.
Advanced studies in lung cancer, colorectal cancer, and head and neck cancers, evaluating novel immunotherapy combinations and targeted treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
